Topic

Aetna (CVS Health)

A collection of 1351 issues

How Long Does It Take to Get Krystexxa (Pegloticase) Approved by Aetna (CVS Health) in Washington? Complete Timeline & Appeal Guide

Answer Box: Getting Krystexxa Approved by Aetna (CVS Health) in Washington Timeline: Standard prior authorization takes 24-72 hours with complete documentation; expedited reviews for urgent cases complete within 24 hours. Requirements: Age 18+, documented failure of conventional gout therapy (allopurinol/febuxostat), serum uric acid ≤6 mg/dL response, G6PD testing,
6 min read

How to Get Daybue (Trofinetide) Covered by Aetna CVS Health in Florida: Complete Coding, Prior Authorization, and Appeals Guide

Answer Box: Getting Daybue Covered by Aetna CVS Health in Florida Eligibility: Aetna requires genetic confirmation of MECP2 mutation, age ≥2 years, and specialist consultation for 12-month initial authorization. Fastest path: Submit prior authorization with ICD-10 F84.2, genetic test results, and clinical manifestations documentation. First step today: Contact your
5 min read

How Long Does It Take to Get Cabometyx (Cabozantinib) Approved by Aetna CVS Health in Pennsylvania? Complete Timeline Guide

Answer Box: Cabometyx (Cabozantinib) Approval Timeline for Aetna CVS Health in Pennsylvania Cabometyx requires a formulary exception from Aetna CVS Health (excluded from Advanced Control formulary), taking 30-45 days for standard review or 72 hours for expedited cases. Pennsylvania residents benefit from a state external review program with 53% success
6 min read

How to Get Stelara (ustekinumab) Covered by Aetna (CVS Health) in California: Prior Authorization, Appeals, and Alternative Options

Quick Answer: Getting Stelara Covered by Aetna in California Aetna (CVS Health) requires prior authorization for Stelara (ustekinumab) with step therapy requirements varying by indication. In California, you have strong appeal rights through the Department of Managed Health Care (DMHC) if denied. First step: Call Aetna at 1-888-632-3862 to confirm
5 min read